Synthesis and SAR study of opioid receptor ligands: mono- and bis-indolomorphinans.

Abstract:

:Mono- and bis-indolomorphinans were synthesized through a multi-step synthetic approach from the alkaloid, thebaine, to further explore the C-ring SAR (structure-activity relationship) of morphinan scaffold. Both mono-indoles displayed good binding affinity and selectivity for the delta receptor, with compound 6b possessed the highest K(i) value of 1.45 nm at this receptor. Bisindolomorphinans 7a,b did not have appreciable affinity for both delta and kappa receptors, but moderate binding at the mu receptor was observed. Functional assays indicated that the newly synthesized mono-indole 6b was delta-agonist, opposite to the delta-antagonist profile of naltrindole. Bisindoles 7a,b were mu-agonists. This work further confirms that the phenol component in opioids is essential for higher binding to the opioid receptors. The different binding ability, receptor selectivity, and the functional activity profiles of naltrindole 2, monoindole 6b, and bisindole 7b clearly indicated that they interact with the opioid receptors in different modes.

journal_name

Chem Biol Drug Des

authors

Li F,Yin C,Chen J,Liu J,Xie X,Zhang A

doi

10.1111/j.1747-0285.2009.00849.x

subject

Has Abstract

pub_date

2009-10-01 00:00:00

pages

335-42

issue

4

eissn

1747-0277

issn

1747-0285

pii

JPP849

journal_volume

74

pub_type

杂志文章
  • Investigation of the bindings of a class of inhibitors with GSK3β kinase using thermodynamic integration MD simulation and kinase assay.

    abstract::GSK3β kinase is a noteworthy target for discovery of the drugs that will be used to treat several diseases. In the effort to identify a new inhibitor lead compound, we utilized thermodynamic integration (TI)-molecular dynamics (MD) simulation and kinase assay to investigate the bindings between GSK3β kinase and five c...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.12946

    authors: Hsu CJ,Hsu WC,Lee DJ,Liu AL,Chang CM,Shih HJ,Huang WH,Lee-Chen GJ,Hsieh-Li HM,Lee GC,Sun YC

    更新日期:2017-08-01 00:00:00

  • Natural compounds with xanthine oxidase inhibitory activity: A review.

    abstract::Hyperuricemia (HUA), a disease due to an elevation of body uric acid level and responsible for various diseases such as gout, cardiovascular disorders, and renal failure, is a major ground debate for the medical science these days. Considering the risk factors linked with allopathic drugs for the treatment of this dis...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章,评审

    doi:10.1111/cbdd.13437

    authors: Mehmood A,Ishaq M,Zhao L,Safdar B,Rehman AU,Munir M,Raza A,Nadeem M,Iqbal W,Wang C

    更新日期:2019-04-01 00:00:00

  • In silico target fishing for the potential targets and molecular mechanisms of baicalein as an antiparkinsonian agent: discovery of the protective effects on NMDA receptor-mediated neurotoxicity.

    abstract::The flavonoid baicalein has been proven effective in animal models of parkinson's disease; however, the potential biological targets and molecular mechanisms underlying the antiparkinsonian action of baicalein have not been fully clarified. In the present study, the potential targets of baicalein were predicted by in ...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.12127

    authors: Gao L,Fang JS,Bai XY,Zhou D,Wang YT,Liu AL,Du GH

    更新日期:2013-06-01 00:00:00

  • Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example.

    abstract::Homology modeling has been applied to fill in the gap in experimental G protein-coupled receptors structure determination. However, achievement of G protein-coupled receptors homology models with ligand selectivity remains challenging due to structural diversity of G protein-coupled receptors. In this work, we propose...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.12607

    authors: Zeng L,Guan M,Jin H,Liu Z,Zhang L

    更新日期:2015-12-01 00:00:00

  • Discovery, optimization, and pharmacophore modeling of oleanolic acid and analogues as breast cancer cell migration and invasion inhibitors through targeting Brk/Paxillin/Rac1 axis.

    abstract::Bioassay-guided fractionation of Terminalia bentzoe L. leaves methanol extract identified the known triterpene oleanolic acid (1) as its major breast cancer cell migration inhibitor. Further chemical optimization afforded five new (9-12 and 15) and seven known (4-8, 13, and 14) semisynthetic analogues. All compounds w...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.12380

    authors: Elsayed HE,Akl MR,Ebrahim HY,Sallam AA,Haggag EG,Kamal AM,El Sayed KA

    更新日期:2015-02-01 00:00:00

  • Computational methodologies for compound database searching that utilize experimental protein-ligand interaction information.

    abstract::Ligand- and target structure-based methods are widely used in virtual screening, but there is currently no methodology available that fully integrates these different approaches. Herein, we provide an overview of various attempts that have been made to combine ligand- and structure-based computational screening method...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章,评审

    doi:10.1111/j.1747-0285.2010.01007.x

    authors: Tan L,Batista J,Bajorath J

    更新日期:2010-09-01 00:00:00

  • The TATA-binding Protein DNA-binding domain of eukaryotic parasites is a potentially druggable target.

    abstract::The TATA-binding protein (TBP) is a central transcription factor in eukaryotes that interacts with a large number of different transcription factors; thus, affecting these interactions will be lethal for any living being. In this work, we present the first structural and dynamic computational study of the surface prop...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.13630

    authors: Santiago Á,Razo-Hernández RS,Pastor N

    更新日期:2020-01-01 00:00:00

  • Synthesis, biological evaluation and molecular modeling studies of N-aryl-2-arylthioacetamides as non-nucleoside HIV-1 reverse transcriptase inhibitors.

    abstract::A series of N-aryl-2-arylthioacetamide derivatives (2-4) designed as non-nucleoside reverse transcriptase inhibitors was synthesized and evaluated for their inhibitory activity against HIV-1 (IIIB) replication in MT-4 cell cultures. The compounds 2-4 were performed by the reaction of thiols and 2-chloro-N-substituted-...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/j.1747-0285.2010.01017.x

    authors: Xiaohe Z,Yu Q,Hong Y,Xiuqing S,Rugang Z

    更新日期:2010-10-01 00:00:00

  • Applications of machine-learning methods for the discovery of NDM-1 inhibitors.

    abstract::The emergence of New Delhi metal beta-lactamase (NDM-1)-producing bacteria and their worldwide spread pose great challenges for the treatment of drug-resistant bacterial infections. These bacteria can hydrolyze most β-lactam antibacterials. Unfortunately, there are no clinically useful NDM-1 inhibitors. In the current...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.13708

    authors: Shi C,Dong F,Zhao G,Zhu N,Lao X,Zheng H

    更新日期:2020-11-01 00:00:00

  • N-pyridin-2-yl benzamide analogues as allosteric activators of glucokinase: Design, synthesis, in vitro, in silico and in vivo evaluation.

    abstract::Glucokinase (GK) is the key enzyme controlling levels of blood glucose under normal physiological range, and GK activators are emerging class of drug candidates with promising hypoglycaemic activity. The current study was planned to design, synthesize and evaluate novel N-pyridin-2-yl benzamide analogues as allosteric...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.13423

    authors: Grewal AS,Kharb R,Prasad DN,Dua JS,Lather V

    更新日期:2019-03-01 00:00:00

  • Modified benzoxazolone derivative as 18-kDa TSPO ligand.

    abstract::We have synthesized six new congeners of acetamidobenzoxazolone for Translocator Protein [18 kDa, TSPO] imaging. The best in vitro binding affinity (10.8 ± 1.2 nm) for TSPO was found for N-methyl-2-(5-(naphthalen-1-yl)-2-oxobenzo[d]oxazol-3(2H)-yl)-N-phenylacetamide, (NBMP). NBMP was synthesised by Suzuki coupling rea...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.12971

    authors: Kumari N,Chadha N,Srivastava P,Mishra LC,Bhagat S,Mishra AK,Tiwari AK

    更新日期:2017-10-01 00:00:00

  • Sertraline/ICG-loaded liposome for dual-modality imaging and effective chemo-photothermal combination therapy against metastatic clear cell renal cell carcinoma.

    abstract::A large number of chemotherapeutic drugs, utilized in the treatment of advanced metastatic clear cell renal cell carcinoma, are typically prone to poor biocompatibility, lack of targeting specificity, and high toxicity, which mostly leads to unsatisfactory clinical outcomes. As a new drug delivery pathway, nanoliposom...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.13652

    authors: Lei Y,Zeng L,Xie S,Fan K,Yu Y,Chen J,Zhang S,Wang Z,Zhong L

    更新日期:2020-03-01 00:00:00

  • Molecular dynamics insights on the role β-augmentation of the peptide N-terminus with binding site β-hairpin of proprotein convertase subtilisin/kexin 9.

    abstract::PCSK9, a member of the proprotein convertase family, is a key negative regulator of hepatic low-density lipoprotein receptor (LDLR) concentrations in the blood plasma and is associated with the risk of coronary artery disease (CAD). Peptide inhibitors designed to block PCSK9-LDLR interactions could reduce the risk of ...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.13612

    authors: Pasam B,Medicherla KM,Rathore RS,Upadhyayula RS

    更新日期:2019-12-01 00:00:00

  • Development of quinoline-based hybrid as inhibitor of methionine aminopeptidase 1 from Leishmania donovani.

    abstract::Methionine aminopeptidase 1 (MetAP1) is a target for drug discovery against many adversaries and a potential antileishmanial target for its role in N-terminal methionine processing. As an effort towards new inhibitor discovery against methionine aminopeptidase 1 from Leishmania donovani (LdMetAP1), we have synthesized...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.13783

    authors: Bhat SY,Bhandari S,Thacker PS,Arifuddin M,Qureshi IA

    更新日期:2021-02-01 00:00:00

  • Investigation into potent inflammation inhibitors from traditional Chinese medicine.

    abstract::Microsomal prostaglandin E synthase-1 (mPGES-1) is the key enzyme for prostaglandin E2 (PGE2) generation during inflammation and is a potential target for designing anti-inflammatory drugs. Potential inhibitors of m-PGES-1 were selected from traditional Chinese medicine (TCM Database@Taiwan) based on the pharmacophore...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/j.1747-0285.2011.01202.x

    authors: Chen KC,Sun MF,Yang SC,Chang SS,Chen HY,Tsai FJ,Chen CY

    更新日期:2011-10-01 00:00:00

  • An attempt to incorporate effect of direct interaction between a ligand and explicit water molecules into MM/3D-RISM.

    abstract::Endpoint methods using continuum-solvent models are widely used to estimate protein-ligand affinity. A recently developed method, MM/3D-RISM, estimates the solvation energy using statistical mechanics by 3D-RISM. This method is theoretically expected to accurately describe solvation effects and to also be less depende...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.13347

    authors: Gohda K

    更新日期:2018-10-01 00:00:00

  • Design of peptidomimetics for inhibition of HER2 receptor dimerization by a combination of virtual screening, MD simulations, and QSAR in silico methods.

    abstract::Malfunction or overexpression of ErbB receptors (epidermal growth factor receptors) is associated with occurrence and severity of several types of cancer. Initiation of signal cascades by ErbB2 (also known as human epidermal growth factor receptor 2/neu) in breast cancer has been blocked by monoclonal antibodies such ...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.12062

    authors: Jamalan M,Zeinali M,Barzegari Asadabadi E

    更新日期:2013-04-01 00:00:00

  • High throughput receptor-based virtual screening under ZINC database, synthesis, and biological evaluation of ketol-acid reductoisomerase inhibitors.

    abstract::Ketol-acid reductoisomerase (KARI; EC 1.1.1.86) catalyzes the second common step in branched-chain amino acid biosynthesis. This enzyme is an important target for drug design. Based on the crystal structure of ketol-acid reductoisomerase/N-hydroxy-N-isopropyloxamate (IpOHA) complex, we have carried out high throughput...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/j.1747-0285.2009.00924.x

    authors: Liu XH,Chen PQ,Wang BL,Dong WL,Li YH,Xie XQ,Li ZM

    更新日期:2010-02-01 00:00:00

  • Inhibition of mycobacterial growth by plumbagin derivatives.

    abstract::Electron transport and respiratory pathways are active in both latent and rapidly growing mycobacteria and remain conserved in all mycobacterial species. In mycobacteria, menaquinone is the sole electron carrier responsible for electron transport. Menaquinone biosynthesis pathway is found to be essential for the growt...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/j.1747-0285.2010.00987.x

    authors: Mathew R,Kruthiventi AK,Prasad JV,Kumar SP,Srinu G,Chatterji D

    更新日期:2010-07-01 00:00:00

  • Dimethylthiazolidine carboxylic acid as a rigid p3 unit in inhibitors of serine proteases: application to two targets.

    abstract::Serine proteases are a very large class of enzymes, many of which represent important targets for therapeutic agents against a wide variety of disease states. The similarity in active site architecture for these proteases has often allowed inhibitor design strategies for a particular target to be successfully applied ...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/j.1747-0285.2009.00870.x

    authors: Kawai SH,Aubry N,Duceppe JS,Llinàs-Brunet M,LaPlante SR

    更新日期:2009-11-01 00:00:00

  • Synthesis, molecular docking and biological evaluation of 1-phenylsulphonyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as novel potential tubulin assembling inhibitors.

    abstract::A series of new 1-phenylsulphonyl-2-(1-methylindol-3-yl)-benzimidazole derivatives were designed, synthesized and evaluated as potential inhibitors of tubulin polymerization and anthropic cancer cell lines. Among them, compound 33 displayed the most potent tubulin polymerization inhibitory activity in vitro (IC50  = 1...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.12932

    authors: Wang YT,Cai XC,Shi TQ,Zhang YL,Wang ZC,Liu CH,Zhu HL

    更新日期:2017-07-01 00:00:00

  • Modeling of compound profiling experiments using support vector machines.

    abstract::Profiling of compounds against target families has become an important approach in pharmaceutical research for the identification of hits and analysis of selectivity and promiscuity patterns. We report on modeling of profiling experiments involving 429 potential inhibitors and a panel of 24 different kinases using sup...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.12294

    authors: Balfer J,Heikamp K,Laufer S,Bajorath J

    更新日期:2014-07-01 00:00:00

  • Binding of matrix metalloproteinase inhibitors to extracellular matrix: 3D-QSAR analysis.

    abstract::Binding to the extracellular matrix, one of the most abundant human protein complexes, significantly affects drug disposition. Specifically, the interactions with extracellular matrix determine the free concentrations of small molecules acting in tissues, including signaling peptides, inhibitors of tissue remodeling e...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/j.1747-0285.2008.00710.x

    authors: Zhang Y,Lukacova V,Bartus V,Nie X,Sun G,Manivannan E,Ghorpade SR,Jin X,Manyem S,Sibi MP,Cook GR,Balaz S

    更新日期:2008-10-01 00:00:00

  • Synthesis of 2-(4-substitutedbenzyl-[1,4]diazepan-1-yl)-n-(1-methyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolin-7-yl)acetamides as inotropic agents.

    abstract::In an attempt to search for more potent positive inotropic agents, a series of N-(4,5-dihydro-1-methyl-[1,2,4]triazolo[4,3-a]quinolin-7-yl)-2-(substitutedbenzyl-[1,4]diazepan-1-yl)acetamides were synthesized and evaluated for positive inotropic activity by measuring left atrium stroke volume in isolated rabbit heart p...

    journal_title:Chemical biology & drug design

    pub_type: 信件

    doi:10.1111/j.1747-0285.2010.01057.x

    authors: Ye BJ,Liu XK,Jiang SM,Cui X,Piao HR

    更新日期:2011-01-01 00:00:00

  • Selective inhibition of TRPM2 channel by two novel synthesized ADPR analogues.

    abstract::Transient receptor potential melastatin-2 (TRPM2) channel critical for monitoring internal body temperature is implicated in the pathological processes such as neurodegeneration. However, lacking selective and potent TRPM2 inhibitors impedes investigation and validation of the channel as a drug target. To discover nov...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.13119

    authors: Luo X,Li M,Zhan K,Yang W,Zhang L,Wang K,Yu P,Zhang L

    更新日期:2018-02-01 00:00:00

  • Comparison of the molecular dynamics and calculated binding free energies for nine FDA-approved HIV-1 PR drugs against subtype B and C-SA HIV PR.

    abstract::We report the first account of a comparative analysis of the binding affinities of nine FDA-approved drugs against subtype B as well as the South African subtype C HIV PR (C-SA). A standardized protocol was used to generate the inhibitor/C-SA PR complexes with the relative positions of the inhibitors taken from the co...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.12063

    authors: Ahmed SM,Kruger HG,Govender T,Maguire GE,Sayed Y,Ibrahim MA,Naicker P,Soliman ME

    更新日期:2013-02-01 00:00:00

  • Boosting Pose Ranking Performance via Rescoring with MM-GBSA.

    abstract::In this self-docking study, we address the so-called scoring problem. The 'scoring problem' is the inability to unambiguously identify biologically the most relevant pose, when the docking score is the main selection criterion. We use the Molecular Mechanics/Generalized Born Surface Area and ChemPLP scoring functions ...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.12763

    authors: Greenidge PA,Lewis RA,Ertl P

    更新日期:2016-09-01 00:00:00

  • Synthesis of ranolazine derivatives containing the (1S,4S)-2,5-diazabicyclo[2.2.1]heptane moiety and their evaluation as vasodilating agents.

    abstract::Two diazabicyclic analogues of ranolazine, (S,S,S)-5 and (S,S,R)-5, and their epimeric mixture were synthesized. Furthermore, their vasomotor effects on rat aorta rings precontracted with phenylephrine were analyzed. These compounds showed vasodilating effects significantly greater than ranolazine. The vasodilating ac...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.12285

    authors: López-Ortiz M,Monsalvo I,Demare P,Paredes C,Mascher D,Hernández C,Hernández M,Regla I

    更新日期:2014-06-01 00:00:00

  • Pharmacophore and QSAR studies to design novel histone deacetylase 2 inhibitors.

    abstract::One pharmacophore model and three quantitative structure-activity relationship models were developed on a series of benzimidazole and imidazole inhibitors of histone deacetylase 2. The goodness of hit score value of the best pharmacophore model was 0.756, which indicated that it is reliable to be used for virtual scre...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/j.1747-0285.2012.01341.x

    authors: Xiang Y,Hou Z,Zhang Z

    更新日期:2012-05-01 00:00:00

  • Reactivity of 9-aminoacridine drug quinacrine with glutathione limits its antiprion activity.

    abstract::Quinacrine-the drug based on 9-aminoacridine-failed in clinical trials for prion diseases, whereas it was active in in vitro studies. We hypothesize that aromatic nucleophilic substitution at C9 could be contributing factor responsible for this failure because of the transfer of acridine moiety from quinacrine to abun...

    journal_title:Chemical biology & drug design

    pub_type: 杂志文章

    doi:10.1111/cbdd.12918

    authors: Šafařík M,Moško T,Zawada Z,Šafaříková E,Dračínský M,Holada K,Šebestík J

    更新日期:2017-06-01 00:00:00